PERSPECTA

News from every angle

← Back to headlines

Pfizer and Arvinas Partner with Rigel for Breast Cancer Therapy Licensing

Pfizer and Arvinas have announced a licensing deal with Rigel Pharmaceuticals for a new breast cancer therapy.

12 May, 11:34 — 12 May, 11:34
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed107d ago

Pfizer, Arvinas ink licensing deal with Rigel for breast cancer therapy

Read full article →

Related Stories

U.S. FDA Approves Landmark Pancreatic Cancer Drug With Improved Survival Rates

1h ago

West Nile Virus Outbreaks Spread Across Greece and North Macedonia

1h ago

Kylie Jenner Reveals Plans for Larger Breast Implants

2h ago

World Health Organization Declares Uganda Ebola Outbreak Over

2h ago